| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |